Lactobacillus is able to alter the virulence and the sensitivity profile of Candida albicans

Journal of Applied Microbiology

Volumn 121, Issue 6, 2016, Pages 1737-1744

  Oliveira, V M C ^a   Santos, S S F ^a   Silva, C R G ^a   Jorge, A O C ^a   Leao M V P ^a  

^a UNIVERSITY OF TAUBATÉ   (Brazil)

Author keywords

biofilm; Candida; Lactobacillus; probiotics; virulence factors

Indexed keywords

BACILLI; BIOFILMS; BLOOD; CONTROLLED DRUG DELIVERY; YEAST;

ANTIFUNGALS; BIOFILM FORMATION; CANDIDA ALBICANS; GERM TUBES; HAEMOLYSINS; LACTOBACILLUS; PROBIOTICS; SENSITIVITY PROFILES; TUBE FORMATION; VIRULENCE FACTORS;

CANDIDA;

AMPHOTERICIN B; FLUCONAZOLE; HEMOLYSIN; KETOCONAZOLE; PHOSPHOLIPASE; PROTEINASE; VIRULENCE FACTOR; ANTIFUNGAL AGENT;

ANTIMICROBIAL ACTIVITY; BACTERIUM; BIOFILM; BIOTECHNOLOGY; ENZYME; FUNGUS; GROWTH; PATHOGENICITY; PROBIOTICS; VIRULENCE;

ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BIOFILM; CANDIDA ALBICANS; CONTROLLED STUDY; ENZYME ACTIVITY; FUNGAL VIRULENCE; FUNGUS ISOLATION; HEMOLYSIS; LACTOBACILLUS RHAMNOSUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; SPECTROPHOTOMETER; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; ISOLATION AND PURIFICATION; METABOLISM; ORGANISMAL INTERACTION; PATHOGENICITY; PHYSIOLOGY;

CANDIDA; CANDIDA ALBICANS; LACTOBACILLUS; LACTOBACILLUS RHAMNOSUS;

ANTIFUNGAL AGENTS; BIOFILMS; CANDIDA ALBICANS; LACTOBACILLUS RHAMNOSUS; MICROBIAL INTERACTIONS; VIRULENCE FACTORS;

EID: 84995695087     PISSN: 13645072     EISSN: 13652672     Source Type: Journal    
DOI: 10.1111/jam.13289     Document Type: Article

References (32)

1. Brown, A.J.P., Budge, S., Kaloriti, D., Tillmann, A., Jacobsen, M.D., Yin, Z., Ene, I.V., Bohovych, I. et al. (2014) Stress adaptation in a pathogenic fungus. J Exp Biol 217, 144–155.
2. Chew, S.Y., Cheah, Y.K., Seow, H.F., Sandai, D. and Than, L.T.L. (2016) Probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 exhibit strong antifungal effects against vulvovaginal candidiasis-causing Candida glabrata isolates. J Appl Microbiol 118, 1180–1190.
3. Clinical and Laboratory Standards Institute (2002) National Committee for Clinical Laboratory Standards. In Reference method for broth dilution antifungal susceptibility testing of yeasts: proposed standard M27-P. NCCLS, Wayne, PA.
4. Enwuru, C., Ogunledun, A., Idika, N., Enwuru, N.V., Ogbonna, F., Aniedobe, M. and Adeiga, A. (2008) Fluconazole resistant opportunistic oro-pharyngeal Candida and non-Candida yeast-like isolates from HIV infected patients attending ARV clinics in Lagos, Nigeria. Afr Health Sci 8, 142–148.
5. Faghfoori, Z., Gargari, B.P., Gharamaleki, A.S., Bagherpour, H. and Khosroushahi, A.Y. (2015) Cellular and molecular mechanisms of probiotics effects on colorectal cancer. J Funct Foods 18, 463–472.
6. Guo, Y., Wei, C., Liu, C., Li, D., Sun, J., Huang, H. and Zhou, H. (2015) Inhibitory effects of oral Actinomyces on the proliferation, virulence and biofilm formation of Candida albicans. Arch Oral Biol 60, 1368–1374.
7. Henriques, M., Azeredo, J. and Oliveira, R. (2006a) Candida albicans and Candida dubliniensis: comparison of biofilm formation in terms of biomass and activity. Br J Biomed Sci 63, 5–11.
8. Henriques, M., Azeredo, J. and Oliveira, R. (2006b) Candida species adhesion to oral epithelium: factors involved and experimental methodology used. Crit Rev Microbiol 32, 217–226.
9. Johnson, L.R. (2008) Microcolony and biofilm formation as a survival strategy for bacteria. J Theor Biol 251, 24–34.
10. Jorjão, A.L., Oliveira, F.E., Leão, M.V.P., Carvalho, C.A.T., Jorge, A.O.C. and Oliveira, L.D. (2015) Live and heat-Killed Lactobacillus rhamnosus ATCC 7469 may induce modulatory cytokines profiles on macrophages RAW 264.7. Sci World 2015, 1–6. doi:10.1155/2015/716749.
11. Kato, I.T., Prates, R.A., Sabino, C.P., Fuchs, B.B., Tegos, G.P., Mylonakis, E., Hamblin, M.R. and Ribeiro, M.S. (2013) Antimicrobial photodynamic inactivation inhibits Candida albicans virulence factors and reduces in vivo pathogenicity. Antimicrob Agents Chemother 57, 445–451.
12. Klaenhammer, T.R., Kleerebezem, M., Kopp, M.V. and Rescigno, M. (2012) The impact of probiotics and prebiotics on the immune system. Nat Rev Immunol 12, 728–734.
13. Lu, Y., Su, C., Unoje, O. and Liu, H. (2014) Quorum sensing controls hyphal initiation in Candida albicans through Ubr1-mediated protein degradation. Proc Natl Acad Sci USA 111, 1975–1980.
14. Martín, R., Sánchez, B., Suárez, J.E. and Urdaci, M.C. (2012) Characterization of the adherence properties of human Lactobacilli strains to be used as vaginal probiotics. FEMS Microbiol Lett 328, 166–173.
15. Martinez, R.C.R., Franceschini, S.A., Patta, M.C., Quintana, S.M., Candido, R.C., Ferreira, J.C., De Martinis, E.C.P. and Reid, G. (2009) Improved treatment of vulvovaginal candidiasis with fluconazole plus probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14. Lett Appl Microbiol 48, 269–274.
16. Mason, K.L., Erb Downward, J.R., Mason, K.D., Falkowski, N.R., Eaton, K.A., Kao, J.Y., Young, V.B. and Huffnagle, G.B. (2012) Candida albicans and bacterial microbiota interactions in the cecum during recolonization following broad-spectrum antibiotic therapy. Infect Immun 80, 3371–3380.
17. Matsubara, V.H., Bandara, H.M.H.N., Mayer, M.P.A. and Samaranayake, L.P. (2016) Probiotics as antifungals in mucosal candidiasis. Clin Infect Dis 62, 1143–1153.
18. Mayer, F.L., Wilson, D. and Hube, B. (2013) Candida albicans pathogenicity mechanisms. Virulence 4, 119–128.
19. Mendonça, F.H.B.P., dos Santos, S.S.F., de Faria, I.D.S., Gonçalves e Silva, C.R., Jorge, A.O.C. and Leão, M.V.P. (2012) Effects of probiotic bacteria on Candida presence and IgA anti-Candida in the oral cavity of elderly. Braz Dent J 23, 534–538.
20. Mohan, V. and Ballal, M. (2008) Proteinase and phospholipase activity as virulence factors in Candida species isolated from blood. Rev Iberoam Micol 25, 208–210.
21. Parahitiyawa, N.B., Samaranayake, Y.H., Samaranayake, L.P., Ye, J., Tsang, P.W.K., Cheung, B.P.K., Yau, J.Y.Y. and Yeung, S.K.W. (2006) Interspecies variation in Candida biofilm formation studied using the Calgary biofilm device. APMIS 114, 298–306.
22. Pietrella, D., Pandey, N., Gabrielli, E., Pericolini, E., Perito, S., Kasper, L., Bistoni, F., Cassone, A. et al. (2013) Secreted aspartic proteases of Candida albicans activate the NLRP3 inflammasome. Eur J Immunol 43, 679–692.
23. Polak, A. (1992) Virulence of a Candida albicans mutants. Mycoses 35, 9–16.
24. Prażyńska, M. and Gospodarek, E. (2014) In vitro effect of amphotericin B on Candida albicans, Candida glabrata and Candida parapsilosis biofilm formation. Mycopathologia 177, 19–27.
25. Radovanovic, I., Mullick, A. and Gros, P. (2011) Genetic control of susceptibility to infection with Candida albicans in mice. PLoS ONE 6, e18957.
26. Rüchel, R., Tegeler, R. and Trost, M. (1982) A comparison of secretory proteinases from different strains of Candida albicans. Sabouraudia 20, 233–244.
27. Samaranayake, Y.H., Ye, J., Yau, J.Y.Y., Cheung, B.P.K. and Samaranayake, L.P. (2005) In vitro method to study antifungal perfusion in Candida biofilms in vitro method to study antifungal perfusion in Candida biofilms. J Clin Microbiol 43, 818–825.
28. Santos, A.L., dos Santos, S.S.F., Gonçalves e Silva, C.R., Jorge, A.O.C. and Leão, M.V.P. (2012) Influence of probiotics on Candida presence and ig-A anti-Candida in the oral cavity. Braz J Microbiol 40, 960–964.
29. Tsang, C.S.P., Chu, F.C.S., Leung, W.K., Jin, L.J., Samaranayake, L.P. and Siu, S.C. (2007) Phospholipase, proteinase and haemolytic activities of Candida albicans isolated from oral cavities of patients with type 2 diabetes mellitus. J Med Microbiol 56, 1393–1398.
30. Tsang, P.W.K., Bandara, H.M.H.N. and Fong, W.P. (2012) Purpurin suppresses Candida albicans biofilm formation and hyphal development. PLoS ONE 7, e50866.
31. Vazquez, J.A. (2010) Optimal management of oropharyngeal and esophageal candidiasis in patients living with HIV infection. Dovepress 2, 89–101.
32. Villena, J., Salva, S., Agüero, G. and Alvarez, S. (2011) Immunomodulatory and protective effect of probiotic Lactobacillus casei against Candida albicans infection in malnourished mice. Microbiol Immunol 55, 434–445.